中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2015年
23期
43-45
,共3页
乳腺癌保乳术%新辅助化疗%乳腺癌%临床效果
乳腺癌保乳術%新輔助化療%乳腺癌%臨床效果
유선암보유술%신보조화료%유선암%림상효과
Breast conserving surgery for breast cancer%Neoadjuvant chemotherapy%Breast cancer%Clinical effect
目的：分析乳腺癌保乳术结合新辅助化疗法治疗乳腺癌的临床效果。方法选取我院自2009年3月~2012年3月收治的68例乳腺癌患者作为研究对象，采取随机数字表法将其分为试验组和对照组，每组各34例，试验组患者采取乳腺癌保乳术结合新辅助化疗的治疗方式，对照组患者则采取乳腺癌改良根治术的治疗方式。对比并分析两组患者的手术情况、治疗后并发症的发生情况及患者的生存情况。结果试验组手术时间、术中出血量、住院时间、术后并发症的发生率均低于对照组，差异均有统计学意义(P<0.05)。试验组在治疗后1、2、3年的生存率均明显高于对照组，差异均有统计学意义(P<0.05)。结论乳腺癌保乳术结合新辅助化疗治疗乳腺癌患者可以明显改善患者的生存质量，降低患者的死亡率并减少不良反应的发生，具有积极的临床价值，可以作为一种安全有效的方法应用于临床工作中。
目的：分析乳腺癌保乳術結閤新輔助化療法治療乳腺癌的臨床效果。方法選取我院自2009年3月~2012年3月收治的68例乳腺癌患者作為研究對象，採取隨機數字錶法將其分為試驗組和對照組，每組各34例，試驗組患者採取乳腺癌保乳術結閤新輔助化療的治療方式，對照組患者則採取乳腺癌改良根治術的治療方式。對比併分析兩組患者的手術情況、治療後併髮癥的髮生情況及患者的生存情況。結果試驗組手術時間、術中齣血量、住院時間、術後併髮癥的髮生率均低于對照組，差異均有統計學意義(P<0.05)。試驗組在治療後1、2、3年的生存率均明顯高于對照組，差異均有統計學意義(P<0.05)。結論乳腺癌保乳術結閤新輔助化療治療乳腺癌患者可以明顯改善患者的生存質量，降低患者的死亡率併減少不良反應的髮生，具有積極的臨床價值，可以作為一種安全有效的方法應用于臨床工作中。
목적：분석유선암보유술결합신보조화요법치료유선암적림상효과。방법선취아원자2009년3월~2012년3월수치적68례유선암환자작위연구대상，채취수궤수자표법장기분위시험조화대조조，매조각34례，시험조환자채취유선암보유술결합신보조화료적치료방식，대조조환자칙채취유선암개량근치술적치료방식。대비병분석량조환자적수술정황、치료후병발증적발생정황급환자적생존정황。결과시험조수술시간、술중출혈량、주원시간、술후병발증적발생솔균저우대조조，차이균유통계학의의(P<0.05)。시험조재치료후1、2、3년적생존솔균명현고우대조조，차이균유통계학의의(P<0.05)。결론유선암보유술결합신보조화료치료유선암환자가이명현개선환자적생존질량，강저환자적사망솔병감소불량반응적발생，구유적겁적림상개치，가이작위일충안전유효적방법응용우림상공작중。
Objective To analyze the clinical efficacy of breast conserving surgery for breast cancer combined with neoadjuvant chemotherapy neoadjuvant therapy on treatment of breast cancer. Methods 68 breast cancer patients in our hospital from March 2009 to March 2012 were selected as the research object,they were randomly divided into ex-perimental group and control group,with 34 cases in each group,experimental group used breast conserving surgery combined with adjuvant chemotherapy,control group used modified radical mastectomy of breast cancer.Two groups’op-eration situation complication incidence and survival after treatment were compared and analyzed. Results Operative time,bleeding volume during operation,hospitalization time,complications rate of experiment group were lower than those of control group with statistical significances (P<0.05).The survival rate of experimental group after 1,2,3 years of treat-ment were significantly higher than those of control group with statistical significances (P<0.05). Conclusion Breast conserving surgery for breast cancer combined with neoadjuvant chemotherapy can significantly improve the life quali-ty and confidence of patients with breast cancer,it reduces patients’ mortality,incidence of adverse reactions and has positive clinical value which can be used as a safe and effective method for clinical work.
